DAFIDA Trademark

Trademark Overview

On Tuesday, January 15, 2013, a trademark application was filed for DAFIDA with the United States Patent and Trademark Office. The USPTO has given the DAFIDA trademark a serial number of 85823779. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 7, 2016. This trademark is owned by Watson Pharmaceuticals, Inc.. The DAFIDA trademark is filed in the Pharmaceutical Products category with the following description:

Contraceptives; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancement preparations
dafida

General Information

Serial Number85823779
Word MarkDAFIDA
Filing DateTuesday, January 15, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 7, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 6, 2013

Trademark Statements

Goods and ServicesContraceptives; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancement preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 22, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameActavis, Inc.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054
Party NameWatson Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054
Party NameWatson Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Trademark Events

Event DateEvent Description
Monday, November 7, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 7, 2016ABANDONMENT - NO USE STATEMENT FILED
Wednesday, April 20, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 19, 2016EXTENSION 5 GRANTED
Friday, April 1, 2016EXTENSION 5 FILED
Friday, April 1, 2016TEAS EXTENSION RECEIVED
Tuesday, October 6, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 5, 2015EXTENSION 4 GRANTED
Thursday, October 1, 2015EXTENSION 4 FILED
Thursday, October 1, 2015TEAS EXTENSION RECEIVED
Tuesday, April 14, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 13, 2015EXTENSION 3 GRANTED
Wednesday, April 1, 2015EXTENSION 3 FILED
Wednesday, April 1, 2015TEAS EXTENSION RECEIVED
Wednesday, October 8, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 7, 2014EXTENSION 2 GRANTED
Tuesday, September 30, 2014EXTENSION 2 FILED
Tuesday, September 30, 2014TEAS EXTENSION RECEIVED
Thursday, April 24, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 23, 2014EXTENSION 1 GRANTED
Thursday, March 27, 2014EXTENSION 1 FILED
Tuesday, April 22, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 27, 2014TEAS EXTENSION RECEIVED
Tuesday, October 1, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, August 28, 2013ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, August 6, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 6, 2013PUBLISHED FOR OPPOSITION
Wednesday, July 17, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 3, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, July 1, 2013ASSIGNED TO LIE
Thursday, June 13, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 13, 2013EXAMINER'S AMENDMENT ENTERED
Thursday, June 13, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, June 13, 2013EXAMINERS AMENDMENT E-MAILED
Thursday, June 13, 2013EXAMINERS AMENDMENT -WRITTEN
Wednesday, May 1, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 1, 2013NON-FINAL ACTION E-MAILED
Wednesday, May 1, 2013NON-FINAL ACTION WRITTEN
Monday, April 29, 2013ASSIGNED TO EXAMINER
Tuesday, January 22, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, January 18, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

dafida preparations pharmaceutical prevention treatment iron symptoms endometriosis anemia osteoporosis fibroids